NCAM1 and neuroblastoma: These phenotypes contrasted with that of CD56++ GD2++ CD10− CD34− CD271−/+ neuroblastoma cells, which allows clear cut identification of neoplastic cells and their discrimination from normal stromal cells in BM, even when BM disseminated NBL cells were present at very low levels (data not shown).